A haplotype-based case-control study examining human extracellular superoxide dismutase gene and essential hypertension

Hypertension Research

Volumn 31, Issue 8, 2008, Pages 1533-1540

  Naganuma, Takahiro ^a,b   Nakayama, Tomohiro ^a   Sato, Naoyuki ^a   Fu, Zhenyan ^a,c   Soma, Masayoshi ^a   Aoi, Noriko ^a   Usami, Ron ^b  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOYO UNIVERSITY   (Japan)

^c XINJIANG MEDICAL UNIVERSITY   (China)

Author keywords

Case control study; Essential hypertension; Extracellular superoxide dismutase; Haplotype; Single nucleotide polymorphism

Indexed keywords

ADENOSINE; SUPEROXIDE DISMUTASE; THYMIDINE;

ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; CONTROLLED STUDY; ESSENTIAL HYPERTENSION; EXTRACELLULAR MATRIX; FEMALE; GENE FREQUENCY; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; MARKER GENE; NUCLEOTIDE SEQUENCE; POPULATION BASED CASE CONTROL STUDY; POPULATION GENETICS; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 55449122813     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1291/hypres.31.1533     Document Type: Article

References (30)

1. Landis GN, Tower J: Superoxide dismutase evolution and life span regulation. Mech Ageing Dev 2005; 126: 365-379.
2. Fattman CL, Schaefer LM, Oury TD: Extracellular superoxide dismutase in biology and medicine. Free Radic Biol Med 2003; 35: 236-256.
3. Umemoto S, Tanaka M, Kawahara S, et al: Calcium antagonist reduces oxidative stress by upregulating Cu/Zn superoxide dismutase in stroke-prone spontaneously hypertensive rats. Hypertens Res 2004; 27: 877-885.
4. Tanaka M, Umemoto S, Kawahara S, et al: Angiotensin II type 1 receptor antagonist and angiotensin-converting enzyme inhibitor altered the activation of Cu/Zn-containing superoxide dismutase in the heart of stroke-prone spontaneously hypertensive rats. Hypertens Res 2005; 28: 67-77.
5. Afonso V, Champy R, Mitrovic D, Collin P, Lomri A: Reactive oxygen species and superoxide dismutases: role in joint diseases. Joint Bone Spine 2007; 74: 324-329.
6. Folz RJ, Guan J, Seldin MF, Oury TD, Enghild JJ, Crapo JD: Mouse extracellular superoxide dismutase: primary structure, tissue-specific gene expression, chromosomal localization, and lung in situ hybridization. Am J Respir Cell Mol Biol 1997; 17: 393-403.
7. Zhou L, Xiang W, Potts J, et al: Reduction in extracellular superoxide dismutase activity in African-American patients with hypertension. Free Radic Biol Med 2006; 41: 1384-1391.
8. Folz RJ, Crapo JD: Extracellular superoxide dismutase (SOD3) tissue-specific expression, genomic characterization, and computer-assisted sequence analysis of the human EC SOD gene. Genomics 1994; 22: 162-171.
9. Campo S, Sardo AM, Campo GM, et al: Extracellular superoxide dismutase (EC-SOD) gene mutations screening in a sample of Mediterranean population. Mutat Res 2005; 578: 143-148.
10. Son M, Cloyd CD, Rothstein JD, Rajendran B, Elliott JL: Aggregate formation in Cu, Zn superoxide dismutase-related proteins. J Biol Chem 2003; 278: 14331-14336.
11. Strålin P, Karlsson K, Johansson BO, Marklund SL: The interstitium of the human arterial wall contains very large amounts of extracellular superoxide dismutase. Arterioscler Thromb Vasc Biol 1995; 15: 2032-2036.
12. Gongora MC, Qin Z, Laude K, et al: Role of extracellular superoxide dismutase in hypertension. Hypertension 2006; 48: 473-481.
13. Welch WJ, Chabrashvili T, Solis G, et al: Role of extracellular superoxide dismutase in the mouse angiotensin slow pressor response. Hypertension 2006; 48: 934-941.
14. Welch WJ, Blau J, Xie H, Chabrashvili T, Wilcox CS: Angiotensin-induced defects in renal oxygenation: role of oxidative stress. Am J Physiol Heart Circ Physiol 2005; 288: H22-H28.
15. Volpe M, Alderman MH, Furberg CD, et al: Beyond hypertension toward guidelines for cardiovascular risk reduction. Am J Hyperens 2004; 17: 1068-1074.
16. Dominiczak AF, Negrin DC, Clark JS, Brosnan MJ, McBride MW, Alexander MY: Genes and hypertension from gene mapping in experimental models to vascular gene transfer strategies. Hypertension 2000; 35: 164-172.
17. Aoi N, Soma M, Nakayama T, et al: Variable number of tandem repeat of the 5′-flanking region of type-C human natriuretic peptide receptor gene influences blood pressure levels in obesity-associated hypertension. Hypertens Res 2004; 27: 711-716.
18. Maruyama A, Nakayama T, Sato N, Mizutani Y, Furuya K, Yamamoto T: Association study using single nucleotide polymorphisms in the estrogen receptor β (ESR2) gene for preeclampsia. Hypertens Res 2004; 27: 903-909.
19. Livak KJ, Marmaro J, Todd JA: Towards fully automated genome-wide polymorphism screening. Nat Genet 1995; 9: 341-342.
20. Kobayashi Y, Nakayama T, Sato N, Izumi Y, Kokubun S, Soma M: Haplotype-based case-control study revealing an association between the adrenomedullin gene and proteinuria in subjects with essential hypertension. Hypertens Res 2005; 28: 229-236.
21. Morita A, Nakayama T, Doba N, Hinohara S, Soma M: Polymorphism of the C-reactive protein (CRP) gene is related to serum CRP level and arterial pulse wave velocity in healthy elderly Japanese. Hypertens Res 2006; 29: 323-331.
22. Hui P, Nakayama T, Morita A, et al: Common single nucleotide polymorphisms in Japanese patients with essential hypertension: aldehyde dehydrogenase 2 gene as a risk factor independent of alcohol consumption. Hypertens Res 2007; 30: 585-592.
23. Tamai M, Furuta H, Kawashima H, et al: Extracellular superoxide dismutase gene polymorphism is associated with insulin resistance and the susceptibility to type 2 diabetes. Diabetes Res Clin Pract 2006; 71: 140-145.
24. Chu Y, Alwahdani A, Iida S, Lund DD, Faraci FM, Heistad DD: Vascular effects of the human extracellular superoxide dimustase R213G variant. Circulation 2005; 112: 1047-1053.
25. Ozaki K, Ohnishi Y, Iida A, et al: Functional SNPs in the lymphotoxin-alpha gene that are associated with susceptibility to myocardial infarction. Nat Genet 2002; 32: 650-654.
26. Zhang K, Calabrese P, Nordborg M, Sun F: Haplotype block structure and its applications to association studies: power and study designs. Am J Hum Genet 2002; 71: 1386-1394.
27. Morris RW, Kaplan NL: On the advantage of haplotype analysis in the presence of multiple disease susceptibility alleles. Genet Epidemiol 2002; 23: 221-233.
28. Sharma P, Hingorani A, Jia H, Hopper R, Brown MJ: Quantitative association between a newly identified molecular variant in the endothelin-2 gene and human essential hypertension. J Hypertens 1999; 9: 1281-1287.
29. Ombra MN, Forabosco P, Casula S, et al: Identification of a new candidate locus for uric acid nephrolithiasis. Am J Hum Genet 2001; 68: 1119-1129.
30. Morita A, Nakayama T, Soma M, Mizutani T: Association between the calcitonin-related peptide alpha (CALCA) gene and essential hypertension in Japanese subjects. Am J Hypertens 2007; 20: 527-532.